List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 110 studies with search of: "Amyloidosis"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting The Effect of Diflunisal on Familial Amyloidosis
Conditions: Familial Amyloid Polyneuropathy;   Familial Amyloidosis
Interventions: Drug: diflunisal;   Other: placebo
2 Withdrawn Mixed Chimeric Transplantation for Primary Amyloidosis
Condition: Amyloidosis
Intervention: Procedure: autologous followed by nonmyeloablative allogeneic transplant
3 Completed Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
Conditions: Secondary (AA) Amyloidosis;   Rheumatoid Arthritis;   Nephrotic Syndrome;   Familial Mediterranean Syndrome;   Kidney Diseases;   Gastrointestinal Diseases
Intervention: Drug: NC-503 (Anti-amyloidotic (AA) Agent)
4 Recruiting Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL Amyloidosis
Condition: Amyloidosis
Interventions: Drug: cyclophosphamide;   Drug: lenalidomide;   Drug: dexamethasone
5 Recruiting Study of Systemic Amyloidosis Presentation and Prognosis
Condition: Amyloidosis
Intervention:
6 Recruiting Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-Diagnosed Light-Chain (AL)-Amyloidosis
Condition: Amyloidosis
Interventions: Drug: Lenalidomide;   Drug: Melphalan;   Drug: Dexamethasone
7 Recruiting A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis
Condition: Primary Amyloidosis
Intervention: Drug: Lenalidomide
8 Recruiting Radioimmunoimaging of AL Amyloidosis
Condition: Primary Amyloidosis
Intervention: Biological: 124I-labeled monoclonal antibody Mu 11-1F4
9 Active, not recruiting The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis
Condition: Transthyretin-Associated Amyloidosis With Polyneuropathy
Intervention: Drug: Fx-1006A
10 Completed Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis
Condition: Primary Systemic Amyloidosis (AL)
Interventions: Drug: Melphalan;   Drug: Dexamethasone;   Procedure: Autologous stem cell transplantation
11 Recruiting Transthyretin-Associated Amyloidoses Outcomes Survey (THAOS)
Condition: TTR-Associated Amyloidosis
Intervention: Other: THAOS is a noninterventional patient registry
12 Active, not recruiting Autologous Stem Cell Rescue for Primary Amyloidosis
Condition: Amyloidosis
Intervention: Procedure: high dose chemo then auto hematopoietic cell transplant
13 Recruiting A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in Primary (AL) Amyloidosis
Condition: Amyloidosis
Interventions: Drug: Lenalidomide;   Drug: Melphalan;   Drug: Dexamethasone
14 Active, not recruiting Efficacy of CC-5013 (Revlimid or Lenalidomide) in Patients With Primary Systemic Amyloidosis
Condition: Amyloidosis
Intervention: Drug: CC-5013
15 Recruiting Open-Label Phase 1/2 Study of VELCADE (Bortezomib) for Injection in Patients With Light-Chain (AL)-Amyloidosis
Condition: Amyloidosis
Intervention: Drug: bortezomib
16 Completed Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis
Condition: Amyloidosis
Interventions: Drug: Melphalan;   Procedure: Autologous Stem Cell Transplantation
17 Suspended Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis
Condition: Primary Systemic Amyloidosis
Intervention: Drug: Enbrel
18 Recruiting Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden
Conditions: Multiple Myeloma;   Primary Amyloidosis
Interventions: Drug: Melphalan;   Procedure: Stem Cell Infusion;   Behavioral: Questionnaires;   Drug: Granulocyte-colony stimulating factor (G-CSF);   Procedure: Apheresis
19 Completed Q-Switched Nd:YAG in Macular Amyloidosis
Condition: Macular Amyloidosis
Intervention: Device: Laser Therapy
20 Recruiting High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Biological: filgrastim;   Drug: cyclophosphamide;   Drug: dexamethasone;   Drug: melphalan;   Drug: thalidomide;   Procedure: peripheral blood stem cell transplantation

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services